Investegate |XBiotech Inc. Announcements | XBiotech Inc.: XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy Appointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D. AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders who specialize in cerebrovascular diseases including ischemic stroke, whi...
Source: investegate.co.uk